Health workers struggle against coronavirus, which affects the whole world. BioNTech, which is working for coronavirus vaccine in Germany, made a promising statement and announced that the first clinical tests of the vaccine it developed were approved. The German Federal Vaccination Institute has announced that the vaccine developed by the BioNTech company will be tested on 200 healthy people between the ages of 18-55. Scientists are studying the effectiveness of the vaccine prototype in immunizing the virus. Germany’s coronavirus vaccine will be tested in the US if approved. In the second phase, additional tests will be carried out on more people, including those at higher risk. BioNTech stated that it has named the vaccine developed together with the pharmaceutical giant Pfizer as BNT162. BNT162 will be tested in the USA after approval in Germany. It was emphasized that the vaccine is the fourth approved coronavirus vaccine worldwide. According to the figures from Johns Hopkins University, the coronavirus caused more than 177,000 people to die, while it infected approximately 2.5 million people. The World Health Organization (WHO) says there are at least 20 different COVID-19 vaccines being developed, including those currently under clinical research. British Health Minister Matt Hancock announced that scientists at Oxford University will start testing a new vaccine on humans tomorrow. After England, Germany has come a long way in finding the vaccine.
